Health Care/Hospital

China Shenghuo Pharmaceutical Holdings, Inc. Announces Listing on American Stock Exchange and Closing of Public Offering

KUNMING, China, June 14 /Xinhua-PRNewswire-FirstCall/ -– China Shenghuo Pharmaceutical Holdings, Inc. (Amex: KUN) announced the listing of its common stock on the American Stock Exchange on Thursday, June 14, 2007, and the closing of a public offering of its common stock at an offering price o...

2007-06-14 21:00 740

Simcere Pharmaceutical Group to Acquire Additional 10% of Equity Interest in Shangdong Simcere Medgenn Bio-Pharmaceutical Co., Ltd.

NANJING, China, June 14 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals in China, and the manufacturer of innovative anti-cancer medication Endu, today announced that it has entered into an agreement to acqui...

2007-06-14 17:39 744

Skystar Receives Approval for 36 New Veterinary Medicines

XI'AN, China, June 11 /Xinhua-PRNewswire-FirstCall/ -- Skystar Bio-Pharmaceutical Co., Ltd. (OTC Bulletin Board: SKBI) ("Skystar"), a leading bio-pharmaceutical company in the People's Republic of China ("PRC"), today announced that it received approval for the production of 36 new veterinary ...

2007-06-11 20:30 613

Sundia Celebrates Strong Growth at its Third Anniversary

SHANGHAI, China, June 8 /Xinhau-PRNewswire/ -- Today Sundia Meditech Company, Ltd. celebrated its recent strong growth at the company's third anniversary party in Shanghai. The main business of this company is to provide contracted research (CRO) services to pharmaceutical and biotech compa...

2007-06-11 09:39 749

BioVeda China to Receive $10 Million Investment from Lilly Asian Ventures

SHANGHAI, China, June 6 /Xinhua-PRNewswire/ -- BioVeda China today announced a $10 Million investment from Lilly Asian Ventures. BioVeda China is the first international venture capital fund focusing on life sciences investments in China. The investment has shown Lilly's commitment to expand i...

2007-06-06 16:57 784

Chindex International Announces Conference Call to Discuss Its Fiscal 2007 Fourth Quarter and Year End Results on Wednesday, June 13, 2007

BETHESDA, Md., June 5 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX) a leading independent American provider of Western healthcare products and services in the People's Republic of China, announced that it intends to release its financial results for the fourth quarter ende...

2007-06-05 19:30 758

Cyprotex Launches New Cloe(R) Screen Assay to Improve the Prediction of in vivo Pharmacokinetics

MANCHESTER, England, June 7 /Xinhua-PRNewswire/ -- Cyprotex announces that it has enhanced the Cloe(R) Screen product offering to include an in vitro assay that assesses the extent to which a compound binds to liver microsomes. When used in conjunction with microsomal stability data, correctio...

2007-06-07 14:00 857

Chindex International, Inc. Adopts Stockholder Rights Plan

BETHESDA, Md., June 5 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX) announced today that its Board of Directors has adopted a Stockholder Rights Plan through the adoption of a Rights Agreement. The Rights Agreement is designed to preserve long-term values and protect...

2007-06-05 06:20 840

Pharmaxis' Aridol Gains European Approval

Asthma Product Now Approved in 14 Countries Across Europe SYDNEY, Australia, June 4 /Xinhua-PRNewswire-FirstCall/ -- The European Mutual Recognition Procedure has successfully completed evaluating the Pharmaxis (ASX: PXS; Nasdaq: PXSL) lung function test Aridol, allowing the 13 European cou...

2007-06-04 21:00 581

TaiGen Biotechnology Announces Election of New Chairman

TAIPEI, Taiwan, June 4 /Xinhua-PRNewswire/ -- TaiGen Biotechnology today announced that current board member, President and Chief Executive Officer, Dr. Ming Chu Hsu, has been unanimously elected as Chairman of the Company's Board of Directors. Dr. Hsu will assume the positi...

2007-06-04 15:36 529

U.S. Preventive Medicine(R) Commends His Highness Sheikh Mohammed Bin Rashid Al Maktoum for his Commitment to Human Development

DALLAS, June 4 /Xinhua-PRNewswire/ -- Today U.S. Preventive Medicine(R), a company working to organize and advance a culture of prevention throughout America and the world, commends the efforts of United Arab Emirates Prime Minister and Ruler of Dubai, His Highness Sheikh Mohammed Bin Ras...

2007-06-04 20:30 642

Avastin(R) Significantly Prolongs Progression Free Survival in Advanced Kidney Cancer

- Patients Have a Chance to Live Almost Twice as Long Without Their Disease Returning CHICAGO, June 4 /Xinhua-PRNewswire/ -- Adding Avastin (bevacizumab) to interferon offers patients with advanced renal cell cancer the chance to live twice as long without their disease advancing ("progress...

2007-06-04 10:27 719

Next Generation of Investigational Anti-Cancer Agents Unveiled at ASCO by AstraZeneca

ALDERLEY PARK, England, June 4 /Xinhua-PRNewswire/ -- AstraZeneca (LSN: AZN; NYSE: AZN) today announced details of two new investigational cancer therapies at the American Society of Clinical Oncology (ASCO) meeting. AZD2281 (KU-0059436) is a small molecule inhibitor of Poly-ADP Ribose Po...

2007-06-04 10:22 700

Avastin(R) Significantly Prolongs Progression Free Survival in Patients With Advanced Lung Cancer

-- Only First-line Treatment to Demonstrate Extended Survival in Over a Decade CHICAGO, June 4 /Xinhua-PRNewswire/ -- Avastin (bevacizumab), significantly improves the time patients with advanced non-small cell lung cancer (NSCLC) live without their disease advancing ("progression fr...

2007-06-04 10:00 520

New Data Show Bondronat(R) Prevents Bone Loss Caused by anastrozole in Women With Surgically Treated Breast Cancer

-- One Year Results From the ARIBON Study Presented at ASCO 2007 CHICAGO, June 6 /Xinhua-PRNewswire/ -- Bondronat(R) (ibandronic acid) has been shown to prevent bone loss caused by anastrozole in post-menopausal women given adjuvant therapy for early breast cancer according to results from ...

2007-06-04 09:59 611

Study Supports Activity of GEMZAR(R) (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer

Five Phase III Early-Stage Breast Cancer Studies Underway With GEMZAR CHICAGO, June 4 /Xinhua-PRNewswire/ -- GEMZAR(R) (gemcitabine HC1 for injection), approved in combination with paclitaxel (Taxol(R)) in the first-line, post-surgical treatment of metastatic breast cancer, was the subject ...

2007-06-04 09:15 632

Sinovac Issues Corporate Update

BEIJING, June 2 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a vaccine-focused biotech company in China, today issued a corporate update. As previously disclosed in Sinovac’s annual report on Form 20-F, Heping Wang, a former director, owed Sinovac outstanding obligations in the...

2007-06-02 04:30 757

Jose Barella Named Executive Chairman of Merial, Ltd.

DULUTH, Ga., June 1 /Xinhua-PRNewswire/ -- The Board of Directors of Merial Ltd., one of the world's leading animal health companies, announced that Jose Barella will succeed Jerry Belle as Executive Chairman of Merial, effective June 1st. Barella has been serving Merial as Chief Oper...

2007-06-01 13:48 770

Message From Dr Henk Bekedam, WHO Representative in China

WORLD NO TOBACCO DAY 31 MAY 2007 BEIJING, May 30 /Xinhua-PRNewswire/ -- World No Tobacco Day 2007 is an urgent reminder that tobacco is a major health challenge in China -- a country that has one third of the world’s smokers. (Logo: http://www.prnasia.com/sa/20061102095006-51.jpg ) ...

2007-05-30 12:00 689

3SBio Inc. to Present at the CIBC World Markets China Dragon Call Conference

SHENYANG, China, May 26 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, will present at the CIBC World Markets China Dragon Call Conference in New ...

2007-05-26 00:24 874
1 ... 761762763764765766767 ... 774